Loading
Latest filing published 01 Aug 2025 for Nuo Therapeutics, Inc., €5,179.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Scott M. Pittman is a declared insider of Nuo Therapeutics, Inc. (board member), with filings sourced from SEC (Form 4). We count 16 filings; the first trade dates from 5 May 2016 and the latest from 30 July 2025.
No open-market sale appears; the market trades are 4 purchases worth €1.2M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 5 share grants and 3 option exercises.
Half of the purchases are above €272k and half below.
The newest entry dates from 1 August 2025: a share grant of €5,179, in Nuo Therapeutics, Inc. The most recent open-market purchase was published on 14 August 2017, 3,357 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations